Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.31 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3277342 | 0.81 | KMT2A (0.36) | FNTAFNTB | |
| SCHEMBL3337614 | 0.80 | KMT2A (0.35) | FNTAFNTB | |
| SCHEMBL3278899 | 0.80 | KMT2A (0.35) | FNTAFNTB | |
| SCHEMBL3277545 | 0.80 | KMT2A (0.35) | FNTAFNTB | |
| SCHEMBL2577651 | 0.78 | HDAC3 (0.36) | — | |
| SCHEMBL12316698 | 0.77 | LMNA (0.36) | ENPEPGSTK1 | |
| SCHEMBL2515854 | 0.77 | ALDH1A1 (0.42) | ENPEPGSTK1 | |
| SCHEMBL3277552 | 0.77 | HDAC3 (0.35) | — | |
| SCHEMBL3278907 | 0.77 | HDAC3 (0.35) | — | |
| SCHEMBL3338583 | 0.77 | HDAC3 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152288-A1 | NOVEL a-LIPOIC ACID DERIVATIVES AND APPLICATIONS THEREOF | SENJU PHARMACEUTICAL CO. LTD. (JP) | 2010-06-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152288-A1 | NOVEL a-LIPOIC ACID DERIVATIVES AND APPLICATIONS THEREOF | TYR, SERPINB1, LPO | FNTA 1365/4885FNTB 1252/4885ENPEP 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.